Map of the northwestern region of Mexico showing the location of the city of Mazatlan (a). by Francisco Flores-de-Santiago (20391063)

PRV UL4 is a promotor of NLRP3 inflammasome activation. by Xiaohua Zhang (350570)

The effect of CWI on blood levels of (A) creatine kinase (CK); (B) CK-muscle brain (CK-MB) and (C) lactate dehydrogenase (LDH) in young healthy males. by Aneta Teległów (9570190)

PRV UL4 is a promotor of NLRP3 inflammasome Activation. by Xiaohua Zhang (350570)

Reagent list. by Adrienne J. Bradley (20861948)

“…We found a significant increase of Iba-1, indicative of microglia activation, although the overall levels of IL-1β, IL-6, TNFα, IL-4, IL-10, and TGFβ mRNA transcripts were not different between the treatment groups. …”

Data for figures. by Adrienne J. Bradley (20861948)

“…We found a significant increase of Iba-1, indicative of microglia activation, although the overall levels of IL-1β, IL-6, TNFα, IL-4, IL-10, and TGFβ mRNA transcripts were not different between the treatment groups. …”

Line graph showing the values of inflammatory cytokines at baseline and after treatment. by Káryta Suely Macêdo Martins (22404155)

Subjects:

Flow diagram of participants selection. by Wei Huang (36889)

Subjects:

Minimal data set. by Wei Huang (36889)

Subjects:

Weighted comparison of baseline characteristics. by Wei Huang (36889)

Subjects:

(a) Electro-hydraulic servo pressure testing machine; (b) Concrete freeze-thaw cycle testing machine. by YongHe Liu (20477123)

Subjects:

Clinical and Demographic Characteristics of the Study Population. by Káryta Suely Macêdo Martins (22404155)

Subjects:

Baseline and post-treatment results of categorical electrocardiographic variables in each study group. by Káryta Suely Macêdo Martins (22404155)

Subjects:

Baseline and post-treatment results of quantitative electrocardiographic variables in each study group. by Káryta Suely Macêdo Martins (22404155)

Subjects:

CONSORT diagram illustrating patient flow during the study. by Káryta Suely Macêdo Martins (22404155)

Subjects:

Baseline and Post-Treatment Results of Echocardiographic Variables in Each Experimental Group. by Káryta Suely Macêdo Martins (22404155)

Subjects:

Baseline and Post-Treatment Serum Levels of NT-proBNP in Each Investigational Group. by Káryta Suely Macêdo Martins (22404155)

Subjects:

Variables obtained from the SF-36 quality of life questionnaire in each experimental group. by Káryta Suely Macêdo Martins (22404155)

Subjects:

Line graph showing the values of myocardial perfusion defects in the study groups. p = ANOVA Mixed Models. by Káryta Suely Macêdo Martins (22404155)

Subjects:

Data. by Chao Zhang (51048)

“…However, the reported rate of urticaria decreased significantly in post-LAW period(P = 0.043). …”